Congenital Hematological Disorder Completed Phase 3 Trials for Vatreptacog alfa (DB12409)

Also known as: Congenital Bleeding Disorder / Congenital bleeding disorders / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01392547Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and InhibitorsTreatment